Skip to main content
Drug Design, Development and Therapy logoLink to Drug Design, Development and Therapy
. 2021 Jan 20;15:231. doi: 10.2147/DDDT.S301054

Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy [Corrigendum]

PMCID: PMC7829596  PMID: 33505157

Zhang X, Deng Y, Xiang J, et al. Drug Des Devel Ther. 2020;14:3393–3405.

The authors have advised that the Acknowledgments statement before the Disclosure section was missed on page 3404 of the published paper. The Acknowledgments statement should read as follows:

Acknowledgments

This work was supported by Youth Program of National Natural Science Foundation of China (21708050), Hunan Provincial Health Committee’s General Subsidy Project (20200100), General Program of National Natural Science Foundation of China (8187032317) and In-hospital Youth Fund of Xiangya Hospital of Central South University (2015Q03).


Articles from Drug Design, Development and Therapy are provided here courtesy of Dove Press

RESOURCES